Business Description
Johnson Chemical Pharmaceutical Works Co
NAICS : 325412
ISIN : TW0004747001
Description
Johnson Chemical Pharmaceutical Works Co is engaged in the manufacturing of pharmaceutical ingredients importing and selling pharmaceutical materials and products. It manufactures drugs in a variety of forms, including solid dosage forms, capsules (soft/hard), tablets (sugar/film-coated), powder and granule, as well as nasal sprays. It offers products in therapeutic areas including the central nervous system, respiratory, cardiovascular, gastrointestinal, and endocrine system, vitamins, anti-inflammatory, cough and cold, and pain relievers. It organization's revenue mainly comes from medical product sales.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.76 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | 1.27 | |||||
| Interest Coverage | 21.53 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.46 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.8 | |||||
| 3-Year EBITDA Growth Rate | 6.9 | |||||
| 3-Year EPS without NRI Growth Rate | 4.7 | |||||
| 3-Year Book Growth Rate | 13.9 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.08 | |||||
| 9-Day RSI | 50.96 | |||||
| 14-Day RSI | 50.98 | |||||
| 6-1 Month Momentum % | -23.01 | |||||
| 12-1 Month Momentum % | 27.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.18 | |||||
| Quick Ratio | 5.54 | |||||
| Cash Ratio | 4.94 | |||||
| Days Inventory | 129.11 | |||||
| Days Sales Outstanding | 61.4 | |||||
| Days Payable | 49.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.71 | |||||
| Dividend Payout Ratio | 0.93 | |||||
| 3-Year Dividend Growth Rate | 7 | |||||
| Forward Dividend Yield % | 2.71 | |||||
| 5-Year Yield-on-Cost % | 2.99 | |||||
| 3-Year Average Share Buyback Ratio | -9.7 | |||||
| Shareholder Yield % | -2.18 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.32 | |||||
| Operating Margin % | 16.3 | |||||
| Net Margin % | 13.14 | |||||
| FCF Margin % | 17.11 | |||||
| ROE % | 6.7 | |||||
| ROA % | 5.27 | |||||
| ROIC % | 10.24 | |||||
| ROC (Joel Greenblatt) % | 15.17 | |||||
| ROCE % | 8.01 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 34.11 | |||||
| PE Ratio without NRI | 34.03 | |||||
| Shiller PE Ratio | 33.14 | |||||
| Price-to-Owner-Earnings | 54.8 | |||||
| PEG Ratio | 7.24 | |||||
| PS Ratio | 4.54 | |||||
| PB Ratio | 1.92 | |||||
| Price-to-Tangible-Book | 1.92 | |||||
| Price-to-Free-Cash-Flow | 27.1 | |||||
| Price-to-Operating-Cash-Flow | 20.7 | |||||
| EV-to-EBIT | 21.59 | |||||
| EV-to-EBITDA | 17.99 | |||||
| EV-to-Revenue | 3.75 | |||||
| EV-to-FCF | 23.25 | |||||
| Price-to-Projected-FCF | 2.22 | |||||
| Price-to-Median-PS-Value | 1.55 | |||||
| Price-to-Peter-Lynch-Fair-Value | 6.55 | |||||
| Price-to-Graham-Number | 1.7 | |||||
| Price-to-Net-Current-Asset-Value | 3.09 | |||||
| Price-to-Net-Cash | 4.18 | |||||
| Earnings Yield (Greenblatt) % | 4.63 | |||||
| FCF Yield % | 3.24 | |||||
| Forward Rate of Return (Yacktman) % | 5.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Johnson Chemical Pharmaceutical Works Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 606.711 | ||
| EPS (TTM) (NT$) | 2.151 | ||
| Beta | -0.21 | ||
| Volatility % | 94.1 | ||
| 14-Day RSI | 50.98 | ||
| 14-Day ATR (NT$) | 2.164477 | ||
| 20-Day SMA (NT$) | 71.38 | ||
| 12-1 Month Momentum % | 27.33 | ||
| 52-Week Range (NT$) | 49.403099 - 122.5 | ||
| Shares Outstanding (Mil) | 43.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Johnson Chemical Pharmaceutical Works Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Johnson Chemical Pharmaceutical Works Co Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Johnson Chemical Pharmaceutical Works Co Frequently Asked Questions
What is Johnson Chemical Pharmaceutical Works Co(ROCO:4747)'s stock price today?
The current price of ROCO:4747 is NT$73.40. The 52 week high of ROCO:4747 is NT$122.50 and 52 week low is NT$49.40.
When is next earnings date of Johnson Chemical Pharmaceutical Works Co(ROCO:4747)?
The next earnings date of Johnson Chemical Pharmaceutical Works Co(ROCO:4747) is .
Does Johnson Chemical Pharmaceutical Works Co(ROCO:4747) pay dividends? If so, how much?
The Dividend Yield %  of Johnson Chemical Pharmaceutical Works Co(ROCO:4747) is 2.71% (As of Today), Highest Dividend Payout Ratio of Johnson Chemical Pharmaceutical Works Co(ROCO:4747) was 1.18. The lowest was 0.31. And the median was 0.89. The  Forward Dividend Yield % of Johnson Chemical Pharmaceutical Works Co(ROCO:4747) is 2.71%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers